Clinical Trial Update: Safety and Benefit of MBX-8025 With and Without Commonly Used Statins in Moderately Overweight Patients With High Cholesterol [Phase 2]

View source ↗

Summary

Phase 2 trial updates on the safety and potential benefit of MBX-8025, with and without concurrent statin therapy, in moderately overweight patients with high c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia

Drugs mentioned

• MBX-8025

Snippet

Sponsor: Gilead Sciences | Conditions: Hyperlipidemia | Phase 2 | Status: COMPLETED